Aditya Bardia
Program Director, Breast Medical Oncology & Assistant Chief, Translational Research, Division of Hematology-Oncology UCLA
Seminars
Tuesday 4th November 2025
Reviewing the ADC Clinical & Approval Landscape: What Direction are ADCs Heading to Reshape Frontline Oncology Treatments For Patients?
8:00 am
- Reviewing the breast cancer patient treatment landscape: Where do ADCs currently fit in with standard of care treatments and how is this evolving?
- Explaining the physician’s perspective and patient attitudes to ADC treatments given anti-tumor efficacy and toxicity profiles
- Assessing the rise of ADC patient resistance mechanisms and explaining the importance of mechanism and design differentiation to provide long-term patient benefit
